Domperidone-associated sudden cardiac death in the general population and implications for use in patients undergoing hemodialysis: a literature review.

PubWeight™: 0.77^‹?›

🔗 View Article (PMC 4275141)

Published in Can J Hosp Pharm on November 01, 2014

Authors

Joy Makari¹, Karen Cameron², Marisa Battistella³

Author Affiliations

1: BScPhm, PharmD, was, during the research and writing phases of this manuscript, a candidate for the Doctor of Pharmacy program at the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario. She is now practising as a Clinical Pharmacist in acute care at Sunnybrook Health Sciences Centre, Toronto, Ontario.
2: BScPhm, is Education Coordinator with the University Health Network, Toronto, Ontario.
3: BScPhm, PharmD, ACPR, is a Clinical Pharmacist with the Hemodialysis Unit of the Toronto General Hospital, University Health Network, and a Pharmacy Clinician Scientist and Assistant Professor with the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario.

Articles citing this ↘

An Herbal Galactagogue Mixture Increases Milk Production and Aquaporin Protein Expression in the Mammary Glands of Lactating Rats. Evid Based Complement Alternat Med (2015) 0.78

Articles cited by this ↗

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77

Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J (2005) 2.72

Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf (2010) 1.66

Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf (2010) 1.64

Effect of domperidone on QT interval in neonates. J Pediatr (2008) 1.61

QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs (2014) 1.25

CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol (2012) 1.20

Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007. MMWR Morb Mortal Wkly Rep (2010) 1.18

Multifactorial QT interval prolongation. Cardiol J (2010) 1.14

Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol (2009) 1.08

QT interval prolongation associated with the oral use of domperidone in an infant. Pediatr Cardiol (2005) 1.05

Domperidone and long QT syndrome. Curr Drug Saf (2010) 0.97

Q-T interval prolongation and ventricular fibrillation with i.v. domperidone. Cancer Treat Rep (1986) 0.91

Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. Hum Toxicol (1985) 0.88

Electrocardiographic findings in chronic hemodialysis patients. J Bras Nefrol (2012) 0.84

Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology (2005) 0.83

Diabetic gastroparesis: Therapeutic options. Diabetes Ther (2010) 0.82

Prokinetics in diabetic gastroparesis. Curr Gastroenterol Rep (2012) 0.78